Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer

In this study, we investigated whether single nucleotide polymorphisms (SNPs) identified by genome-wide association study (GWAS) (MAP3K1, FGFR2, TNRC9, HCN1, and 5p12), and SNPs involved in the metabolism of estrogen (CYP19, COMT, ESR1, and UGT1A1), tamoxifen (CYP2C9, CYP2C19, CYP3A5, and CYP2D6), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Sung-Hsin, Yang, Shi-Yi, You, San-Lin, Lien, Huang-Chun, Lin, Ching-Hung, Lin, Po-Han, Huang, Chiun-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400556/
https://www.ncbi.nlm.nih.gov/pubmed/28178648
http://dx.doi.org/10.18632/oncotarget.14995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400556/
https://www.ncbi.nlm.nih.gov/pubmed/28178648
http://dx.doi.org/10.18632/oncotarget.14995

Ejemplares similares